CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for BioHemp International Inc is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

BioHemp International Inc
244 5th Ave Ste A154
Phone: (646) 453-4912p:646 453-4912 NEW YORK, NY  10001-7604  United States
This company is no longer actively traded on any major stock exchange.
Business Summary
BioHemp International, Inc., formerly Blake Insomnia Therapeutics, Inc., is a development-stage pharmaceutical company. The Company operates as a provider of insomnia remedy. The Company is focused on developing its business plan for an insomnia medication known as Zleepax. Zleepax is a sleep aid with beta-blockers as an active agent. As of August 31, 2016, the Company had no revenues.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
-Yes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
5/31/20198/31/2018YesYes---

Industries
SIC Code Description
2834 Pharmaceutical preparations

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
President, Chief Executive Officer, Treasurer, Secretary, Director DanielBlum 30 5/15/2019 5/15/2019
Director AjitJohal 5/25/2017 5/25/2017
Director KyleSarwal 5/25/2017 5/25/2017

Business Names
Business Name
BKIT
BKITD

General Information
Outstanding Shares: 2,487,063 (As of 5/31/2019)
Shareholders: 38
Stock Exchange: OTC
Federal Tax Id: 460780380


Copyright © 2023 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Friday, July 21, 2023